Big discounting Methyl 2-Hydroxy-3-Methoxy-3 3-Diphenylpropanoate - 3-Benzyl-6-Bromo-2-Chloroquinoline CAS 654655-68-2 Bedaquiline Fumarate Intermediate Purity ≥99.0% (HPLC) Factory – Ruifu

Short Description:


Product Detail

Related Products

Product Tags

Related Video

Feedback (2)

We take pleasure in an exceptionally excellent status between our buyers for our superb merchandise good quality, aggressive price tag and the greatest support for CAS 438056-69-0, Remdesivir CAS 1809249-37-3, Formula Weight 269.34, We promise to try our best to provide you with high quality and efficient services.
Big discounting Methyl 2-Hydroxy-3-Methoxy-3 3-Diphenylpropanoate - 3-Benzyl-6-Bromo-2-Chloroquinoline CAS 654655-68-2 Bedaquiline Fumarate Intermediate Purity ≥99.0% (HPLC) Factory – Ruifu Detail:

Commercial Supply Bedaquiline Related Intermediates:
3-Benzyl-6-Bbromo-2-Mmethoxyquinoline CAS: 654655-69-3
3-Benzyl-6-Bromo-2-Chloroquinoline CAS: 654655-68-2
3-(Dimethylamino)-1-(Naphthalen-1-yl)propan-1-one Hydrochloride CAS: 5409-58-5  
Bedaquiline Fumarate CAS: 845533-86-0

Chemical Name 3-Benzyl-6-Bromo-2-Chloroquinoline
Synonyms 6-Bromo-2-Chloro-3-(Phenylmethyl)quinoline; Bedaquiline Impurity B; Bedaquiline Fumarate Impurity 5
CAS Number 654655-68-2 
CAT Number RF-PI107
Stock Status In Stock, Production Scale Up to Tons
Molecular Formula C₁₆H₁₁BrClN
Molecular Weight 332.62
Brand Ruifu Chemical
Item Specifications
Appearance White to Off-White or Light Yellow Powder
Purity / Analysis Method ≥99.0% (HPLC)
Melting Point 100.0~120.0℃
Moisture (K.F) ≤0.50%
Residue on ignition ≤0.50%
Total Impurities ≤1.00%
Test Standard Enterprise Standard
Usage Intermediate of Bedaquiline Fumarate (CAS: 845533-86-0)

3
10
121

3-Benzyl-6-bromo-2-chloroquinoline (CAS: 654655-68-2) is a main intermediate of Bedaquiline Fumarate (CAS: 845533-86-0). Bedaquiline Fumarate is a diarylquinone drug developed by Janssen Pharmaceutical. The drug, which was approved in 2012 for the treatment of multidrug-resistant tuberculosis (MDR-TB), was developed in partnership with Johnson & Johnson and represents the first new tuberculosis therapy approved in over four decades. Bedaquiline Fumarate used in combination therapy for the treatment of pulmonary multi-drug resistant tuberculosis by inhibition of ATP synthase, an enzyme essential for the replication of th mycobacteria.


Product detail pictures:

Big discounting Methyl 2-Hydroxy-3-Methoxy-3 3-Diphenylpropanoate - 3-Benzyl-6-Bromo-2-Chloroquinoline CAS 654655-68-2 Bedaquiline Fumarate Intermediate Purity ≥99.0% (HPLC) Factory – Ruifu detail pictures


Related Product Guide:

We consistently carry out our spirit of ''Innovation bringing development, Highly-quality ensuring subsistence, Management promoting benefit, Credit attracting customers for Big discounting Methyl 2-Hydroxy-3-Methoxy-3 3-Diphenylpropanoate - 3-Benzyl-6-Bromo-2-Chloroquinoline CAS 654655-68-2 Bedaquiline Fumarate Intermediate Purity ≥99.0% (HPLC) Factory – Ruifu , The product will supply to all over the world, such as: Milan, Rotterdam, Romania, Profession, Devoting are always fundamental to our mission. We have always been in line with serving customers, creating value management objectives and adhering to the sincerity, dedication, persistent management idea.
  • With a positive attitude of "regard the market, regard the custom, regard the science", the company works actively to do research and development. Hope we have a future business relationships and achieving mutual success.
    5 Stars By Olivia from Mexico - 2018.11.06 10:04
    Factory equipment is advanced in the industry and the product is fine workmanship, moreover the price is very cheap, value for money!
    5 Stars By Athena from El Salvador - 2018.11.22 12:28
    Write your message here and send it to us